Clinical outcomes | ICU COVID-19 Negative (N = 93) | ICU COVID-19 Positive (N = 78) | Unadjusted relative risk (95% CI) | p value | Model 1 relative risk (95% CI) | p value | Model 2 relative risk (95% CI) | p value |
---|---|---|---|---|---|---|---|---|
In-hospital mortality | 20 (22) | 20 (26) | 1.19 (0.69, 2.05) | 0.53 | 1.24 (0.74, 2.10) | 0.41 | 1.50 (0.93, 2.41) | 0.10 |
ARDS | 23 (25) | 28 (36) | 1.45 (0.91, 2.30) | 0.11 | 1.39 (0.87, 2.22) | 0.17 | 1.32 (0.87, 1.98) | 0.19 |
Shock requiring vasopressor therapy | 43 (46) | 39 (50) | 1.08 (0.79, 1.48) | 0.62 | 1.07 (0.79, 1.45) | 0.67 | 1.14 (0.84, 1.54) | 0.40 |
AKIa | 24 (26) | 23 (29) | 1.06 (0.66, 1.71) | 0.81 | 0.96 (0.60, 1.54) | 0.86 | 1.04 (0.64, 1.69) | 0.87 |
Severe AKIa | 11 (12) | 12 (15) | 1.21 (0.57, 2.57) | 0.63 | 1.08 (0.50, 2.31) | 0.85 | 1.13 (0.51, 2.52) | 0.77 |
New dialysisa | 6 (6) | 8 (10) | 1.48 (0.54, 4.06) | 0.45 | 1.31 (0.48, 3.58) | 0.60 | 1.60 (0.63, 4.09) | 0.33 |
Thromboembolism | 14 (15) | 11 (14) | 0.94 (0.45, 1.94) | 0.86 | 0.83 (0.40, 1.71) | 0.62 | 0.60 (0.28, 1.27) | 0.18 |